186 related articles for article (PubMed ID: 18166944)
21. Severe acute lung injury induced by gemcitabine.
Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Dalbagni G; Russo P; Sheinfeld J; Mazumdar M; Tong W; Rabbani F; Donat MS; Herr HW; Sogani P; dePalma D; Bajorin D
J Clin Oncol; 2002 Aug; 20(15):3193-8. PubMed ID: 12149290
[TBL] [Abstract][Full Text] [Related]
23. Severe pulmonary toxicity in a patient treated with gemcitabine.
Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
[TBL] [Abstract][Full Text] [Related]
24. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
Fleming DR; Glisson SD; Bhupalam L; Michelson GD; Goldsmith GH; LaRocca RV
Am J Clin Oncol; 2000 Aug; 23(4):349-52. PubMed ID: 10955861
[TBL] [Abstract][Full Text] [Related]
26. Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.
De Berardinis E; Antonini G; Peters GJ; Loves WJ; Van der Born K; Codacci-Pisanelli G; Di Silverio F
BJU Int; 2004 Mar; 93(4):491-4. PubMed ID: 15008715
[TBL] [Abstract][Full Text] [Related]
27. Intravesical gemcitabine for non-muscle invasive bladder cancer.
Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin.
Millikan RE; Plunkett WK; Smith TL; Williams DL; Logothetis CJ
Cancer; 2001 Jul; 92(1):194-9. PubMed ID: 11443627
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine-induced systemic capillary leak syndrome.
De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
[TBL] [Abstract][Full Text] [Related]
31. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
33. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
Belknap SM; Kuzel TM; Yarnold PR; Slimack N; Lyons EA; Raisch DW; Bennett CL
Cancer; 2006 May; 106(9):2051-7. PubMed ID: 16568459
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
Cao M; Ma CK; Ma J; Chen HG; Xue W
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):385-7. PubMed ID: 21875472
[TBL] [Abstract][Full Text] [Related]
36. Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial.
Kent E; Sandler H; Montie J; Lee C; Herman J; Esper P; Fardig J; Smith DC
J Clin Oncol; 2004 Jul; 22(13):2540-5. PubMed ID: 15226322
[TBL] [Abstract][Full Text] [Related]
37. [Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity].
Stern JB; Caliandro R; Lamer C; Lenoir S; Théodore C; Grunenwald D; Girard P
Rev Mal Respir; 2002 Apr; 19(2 Pt1):253-6. PubMed ID: 12040327
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.
Birlik M; Akar S; Tuzel E; Onen F; Ozer E; Manisali M; Kirkali Z; Akkoc N
J Cancer Res Clin Oncol; 2004 Feb; 130(2):122-5. PubMed ID: 14745551
[TBL] [Abstract][Full Text] [Related]
39. Role of gemcitabine in cancer therapy.
Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine induced digital ischaemia and necrosis.
Holstein A; Bätge R; Egberts EH
Eur J Cancer Care (Engl); 2010 May; 19(3):408-9. PubMed ID: 19490003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
